Shin Nippon Biomedical Laboratories : 2018 Prime Minister's Award
December 21, 2018 at 02:00 am EST
Share
SNBL has received the 2018 Prime Minister's Award for leading businesses in the promotion of women from the Gender Equality Bureau Cabinet Office. This award recognizes companies that make a proactive effort in supporting women in managerial and executive positions. SNBL is the first company in Kagoshima to receive this award. SNBL knows that the viewpoints of women are essential not only to a successful business, but also to a prosperous society. We are honored to receive this award and hope that our practices can be a model for the rest of Kagoshima.
Attachments
Original document
Permalink
Disclaimer
Shin Nippon Biomedical Laboratories Ltd. published this content on 21 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 December 2018 06:59:04 UTC
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 
